Affibody Medical Investor Relations
Categories:
Navigation:
Regulatory
March 7, 2023
Affibody and Chiesi Group collaborate to develop and commercialize innovative treatments for respiratory diseases
Affibody and Chiesi Group will collaborate closely to develop novel Affibody® molecules as innovative treatments for respiratory diseases. This agreement expands Chiesi’s comprehensive R&D program in respiratory diseases with...
Read more
